Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Sun Pharmaceutical Industries is the largest pharmaceutical company in India and is a leading generic company in the US as well as Global Emerging Markets.
The company’s consolidated net profit tumbled 19.64% to Rs 2,278.63 crore despite of 10.07% increase in revenue from operations to Rs 13,786.07 crore in Q1 FY26 over Q1 FY25. The drop in profit was primarily due to a one-time exceptional charge of Rs 818 crore during the quarter.
Sun Pharmaceutical Industries Ltd gained for a third straight session today. The stock is quoting at Rs 1640.3, up 1.12% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.56% on the day, quoting at 24624.55. The Sensex is at 80559.71, up 0.4%. Sun Pharmaceutical Industries Ltd has slipped around 2.51% in last one month.
Meanwhile, Nifty Pharma index of which Sun Pharmaceutical Industries Ltd is a constituent, has slipped around 1.12% in last one month and is currently quoting at 21753.5, up 1.87% on the day. The volume in the stock stood at 5.36 lakh shares today, compared to the daily average of 21.96 lakh shares in last one month.
The benchmark August futures contract for the stock is quoting at Rs 1642.4, up 1.12% on the day. Sun Pharmaceutical Industries Ltd is down 5.82% in last one year as compared to a 1.99% spurt in NIFTY and a 0.67% spurt in the Nifty Pharma index.
The PE of the stock is 78.13 based on TTM earnings ending June 25.